nach oben

Familial Cancer

Erschienen in:

01.12.2014 | Original Article

Genetic 135G/C polymorphism of RAD51 gene and risk of cancer: a meta-analysis of 28,956 cases and 28,372 controls

verfasst von: Bei-bei Zhang, Dao-gang Wang, Chao Xuan, Gui-li Sun, Kai-feng Deng

Erschienen in: Familial Cancer | Ausgabe 4/2014

Einloggen, um Zugang zu erhalten

Abstract

The RAD51 gene is essential for the repair of damaged DNA related to tumor development. Although a number of genetic studies have attempted to link the 135G/C polymorphism of RAD51 gene to the risk of cancer, the results were inconclusive. The present study aimed at investigating the pooled association using the more comprehensive meta-analysis. The PubMed, EBSCO, and BIOSIS databases were searched to identify eligible studies which were published in English before March 2014. Data were extracted using standardized methods. The association was assessed by odds ratio (OR) with 95 % confidence interval (CI). Begg’s test was used to measure publication bias. Sensitivity analyses were also performed to assess the stability of the results. A total of 45 eligible studies with 28,956 patients and 28,372 controls were included in this meta-analysis. Overall, significant association was detected between 135G/C polymorphism and increased cancer risk (C allele vs. G allele: OR 1.23, 95 % CI 1.18–1.28; CC vs. GG: OR 2.41, 95 % CI 2.12–2.74; CC vs. CG: OR 3.86, 95 % CI 3.41–4.37; recessive model: OR 3.57, 95 % CI 3.19–4.00). In further stratified analysis, significantly elevated cancer risk was observed among Caucasians but not Asians. Subgroup analysis by different cancers also showed their significant associations in breast cancer, hematologic malignances, ovarian cancer, colorectal cancer and endometrial cancer, but not in head and neck cancer. Our results indicated that the RAD51 135G/C polymorphism was a candidate for susceptibility of cancer. The effect of the variants on the expression levels and the possible functional role of the variants in different cancers should be addressed in further studies.

Pharoah PD, Dunning AM, Ponder BA, Easton DF (2004) Association studies for finding cancer-susceptibility genetic variants. Nat Rev Cancer 4(11):850–860PubMedCrossRef

Cheng D, Shi H, Zhang K, Yi L, Zhen G (2014) RAD51 Gene 135G/C polymorphism and the risk of four types of common cancers: a meta-analysis. Diagn Pathol 9:18PubMedCentralPubMedCrossRef

Bredberg A (2011) Cancer: more of polygenic disease and less of multiple mutations? A quantitative viewpoint. Cancer 117(3):440–445PubMedCrossRef

Hoeijmakers JH (2001) Genome maintenance mechanisms for preventing cancer. Nature 411(6835):366–374PubMedCrossRef

Krajinovic M, Labuda D, Mathonnet G et al (2002) Polymorphisms in genes encoding drugs and xenobiotic metabolizing enzymes, DNA repair enzymes, and response to treatment of childhood acute lymphoblastic leukemia. Clin Cancer Res Off J Am Assoc Cancer Res 8(3):802–810

Finch SC (2007) Radiation-induced leukemia: lessons from history. Best Pract Res Clin Haematol 20(1):109–118PubMedCrossRef

Alexander FE, Patheal SL, Biondi A et al (2001) Transplacental chemical exposure and risk of infant leukemia with MLL gene fusion. Cancer Res 61(6):2542–2546PubMed

Shinohara A, Ogawa H, Matsuda Y, Ushio N, Ikeo K, Ogawa T (1993) Cloning of human, mouse and fission yeast recombination genes homologous to RAD51 and recA. Nat Genet 4(3):239–243PubMedCrossRef

Zhao M, Chen P, Dong Y, Zhu X, Zhang X (2014) Relationship between Rad51 G135C and G172T variants and the susceptibility to cancer: a meta-analysis involving 54 case-control studies. PLoS ONE 9(1):e87259PubMedCentralPubMedCrossRef

10.

Vispe S, Defais M (1997) Mammalian Rad51 protein: a RecA homologue with pleiotropic functions. Biochimie 79(9–10):587–592PubMedCrossRef

11.

Baumann P, West SC (1998) Role of the human RAD51 protein in homologous recombination and double-stranded-break repair. Trends Biochem Sci 23(7):247–251PubMedCrossRef

12.

Thacker J (2005) The RAD51 gene family, genetic instability and cancer. Cancer Lett 219(2):125–135PubMedCrossRef

13.

Richardson C (2005) RAD51, genomic stability, and tumorigenesis. Cancer Lett 218(2):127–139PubMedCrossRef

14.

Hasselbach L, Haase S, Fischer D, Kolberg HC, Sturzbecher HW (2005) Characterisation of the promoter region of the human DNA-repair gene Rad51. Eur J Gynaecol Oncol 26(6):589–598PubMed

15.

Kawabata M, Kawabata T, Nishibori M (2005) Role of recA/RAD51 family proteins in mammals. Acta Med Okayama 59(1):1–9PubMed

16.

Gao LB, Pan XM, Li LJ et al (2011) RAD51 135G/C polymorphism and breast cancer risk: a meta-analysis from 21 studies. Breast Cancer Res Treat 125(3):827–835PubMedCrossRef

17.

Wang Z, Dong H, Fu Y, Ding H (2010) RAD51 135G > C polymorphism contributes to breast cancer susceptibility: a meta-analysis involving 26,444 subjects. Breast Cancer Res Treat 124(3):765–769PubMedCrossRef

18.

Yu KD, Yang C, Fan L, Chen AX, Shao ZM (2011) RAD51 135G > C does not modify breast cancer risk in non-BRCA1/2 mutation carriers: evidence from a meta-analysis of 12 studies. Breast Cancer Res Treat 126(2):365–371PubMedCrossRef

19.

Xuan C, Zhang BB, Yang T, Deng KF, Li M, Tian RJ (2012) Association between OCTN1/2 gene polymorphisms (1672C-T, 207G-C) and susceptibility of Crohn’s disease: a meta-analysis. Int J Colorectal Dis 27(1):11–19PubMedCrossRef

20.

Zhang BB, Xuan C, Deng KF, Wu N, Lun LM (2013) Association between the MDR1 gene variant C3435T and risk of leukaemia: a meta-analysis. Euro J Cancer Care 22(5):617–625CrossRef

21.

Xuan C, Lun LM, Zhao JX et al (2013) PTPN22 gene polymorphism (C1858T) is associated with susceptibility to type 1 diabetes: a meta-analysis of 19,495 cases and 25,341 controls. Ann Hum Genet 77(3):191–203PubMedCrossRef

22.

Kuschel B, Auranen A, McBride S et al (2002) Variants in DNA double-strand break repair genes and breast cancer susceptibility. Hum Mol Genet 11(12):1399–1407PubMedCrossRef

23.

Wang LE, Bondy ML, Shen H et al (2004) Polymorphisms of DNA repair genes and risk of glioma. Cancer Res 64(16):5560–5563PubMedCrossRef

24.

Seedhouse C, Faulkner R, Ashraf N, Das-Gupta E, Russell N (2004) Polymorphisms in genes involved in homologous recombination repair interact to increase the risk of developing acute myeloid leukemia. Clin Cancer Res Off J Am Assoc Cancer Res 10(8):2675–2680CrossRef

25.

Sliwinski T, Krupa R, Majsterek I et al (2005) Polymorphisms of the BRCA2 and RAD51 genes in breast cancer. Breast Cancer Res Treat 94(2):105–109PubMedCrossRef

26.

Webb PM, Hopper JL, Newman B et al (2005) Double-strand break repair gene polymorphisms and risk of breast or ovarian cancer. Cancer Epidemiol Biomark Prev Publ Am Assoc Cancer Res Cosponsored Am Soc Prev Oncol 14(2):319–323CrossRef

27.

Lee KM, Choi JY, Kang C et al (2005) Genetic polymorphisms of selected DNA repair genes, estrogen and progesterone receptor status, and breast cancer risk. Clin Cancer Res Off J Am Assoc Cancer Res 11(12):4620–4626CrossRef

28.

Auranen A, Song H, Waterfall C et al (2005) Polymorphisms in DNA repair genes and epithelial ovarian cancer risk. Int J Cancer J Int du Cancer 117(4):611–618CrossRef

29.

Tarasov VA, Aslanyan MM, Tsyrendorzhiyeva ES, Litvinov SS, Gar’kavtseva RF, Altukhov YP (2006) Genetically determined subdivision of human populations with respect to the risk of breast cancer in women. Doklady biological sciences. In: proceedings of the Academy of Sciences of the USSR, Biological sciences sections/translated from Russian 406: 66–69

30.

Romanowicz-Makowska H, Smolarz B, Zadrozny M, Kulig A (2006) Analysis of RAD51 polymorphism and BRCA1 mutations in Polish women with breast cancer. Exp Oncol 28(2):156–159PubMed

31.

Poplawski T, Arabski M, Kozirowska D et al (2006) DNA damage and repair in gastric cancer—a correlation with the hOGG1 and RAD51 genes polymorphisms. Mutat Res 601(1–2):83–91PubMedCrossRef

32.

Rollinson S, Smith AG, Allan JM et al (2007) RAD51 homologous recombination repair gene haplotypes and risk of acute myeloid leukaemia. Leuk Res 31(2):169–174PubMedCrossRef

33.

Jakubowska A, Gronwald J, Menkiszak J et al (2007) The RAD51 135 G > C polymorphism modifies breast cancer and ovarian cancer risk in Polish BRCA1 mutation carriers. Cancer Epidemiol Biomark Prev Publ Am Assoc Cancer Res Cosponsored Am Soc Prev Oncol 16(2):270–275CrossRef

34.

Lu J, Wang LE, Xiong P, Sturgis EM, Spitz MR, Wei Q (2007) 172G > T variant in the 5′ untranslated region of DNA repair gene RAD51 reduces risk of squamous cell carcinoma of the head and neck and interacts with a P53 codon 72 variant. Carcinogenesis 28(5):988–994PubMedCrossRef

35.

Jara L, Acevedo ML, Blanco R et al (2007) RAD51 135G > C polymorphism and risk of familial breast cancer in a South American population. Cancer Genet Cytogenet 178(1):65–69PubMedCrossRef

36.

Costa S, Pinto D, Pereira D et al (2007) DNA repair polymorphisms might contribute differentially on familial and sporadic breast cancer susceptibility: a study on a Portuguese population. Breast Cancer Res Treat 103(2):209–217PubMedCrossRef

37.

Antoniou AC, Sinilnikova OM, Simard J et al (2007) RAD51 135G → C modifies breast cancer risk among BRCA2 mutation carriers: results from a combined analysis of 19 studies. Am J Hum Genet 81(6):1186–1200PubMedCentralPubMedCrossRef

38.

Pharoah PD, Tyrer J, Dunning AM, Easton DF, Ponder BA (2007) Association between common variation in 120 candidate genes and breast cancer risk. PLoS Genet 3(3):e42PubMedCentralPubMedCrossRef

39.

Voso MT, Fabiani E, D’Alo F et al (2007) Increased risk of acute myeloid leukaemia due to polymorphisms in detoxification and DNA repair enzymes. Ann Oncol Off J Euro Soc Med Oncol ESMO 18(9):1523–1528CrossRef

40.

Figueroa JD, Malats N, Rothman N et al (2007) Evaluation of genetic variation in the double-strand break repair pathway and bladder cancer risk. Carcinogenesis 28(8):1788–1793PubMedCrossRef

41.

Synowiec E, Stefanska J, Morawiec Z, Blasiak J, Wozniak K (2008) Association between DNA damage, DNA repair genes variability and clinical characteristics in breast cancer patients. Mutat Res 648(1–2):65–72PubMedCrossRef

42.

Bhatla D, Gerbing RB, Alonzo TA et al (2008) DNA repair polymorphisms and outcome of chemotherapy for acute myelogenous leukemia: a report from the Children’s Oncology Group. Leukemia 22(2):265–272PubMedCentralPubMedCrossRef

43.

Werbrouck J, De Ruyck K, Duprez F et al (2008) Single-nucleotide polymorphisms in DNA double-strand break repair genes: association with head and neck cancer and interaction with tobacco use and alcohol consumption. Mutat Res 656(1–2):74–81PubMedCrossRef

44.

Jakubowska A, Jaworska K, Cybulski C et al (2009) Do BRCA1 modifiers also affect the risk of breast cancer in non-carriers? Eur J Cancer 45(5):837–842PubMedCrossRef

45.

Fabiani E, D’Alo F, Scardocci A et al (2009) Polymorphisms of detoxification and DNA repair enzymes in myelodyplastic syndromes. Leuk Res 33(8):1068–1071PubMedCrossRef

46.

Krupa R, Synowiec E, Pawlowska E et al (2009) Polymorphism of the homologous recombination repair genes RAD51 and XRCC3 in breast cancer. Exp Mol Pathol 87(1):32–35PubMedCrossRef

47.

Krupa R, Sobczuk A, Poplawski T, Wozniak K, Blasiak J (2011) DNA damage and repair in endometrial cancer in correlation with the hOGG1 and RAD51 genes polymorphism. Mol Biol Rep 38(2):1163–1170PubMedCentralPubMedCrossRef

48.

Jara L, Dubois K, Gaete D et al (2010) Variants in DNA double-strand break repair genes and risk of familial breast cancer in a South American population. Breast Cancer Res Treat 122(3):813–822PubMedCrossRef

49.

Romanowicz H, Smolarz B, Baszczynski J, Zadrozny M, Kulig A (2010) Genetics polymorphism in DNA repair genes by base excision repair pathway (XRCC1) and homologous recombination (XRCC2 and RAD51) and the risk of breast carcinoma in the Polish population. Pol J Pathol Off J Polish Soc Pathol 61(4):206–212

50.

Pasaje CF, Kim JH, Park BL et al (2011) Lack of association of RAD51 genetic variations with hepatitis B virus clearance and occurrence of hepatocellular carcinoma in a Korean population. J Med Virol 83(11):1892–1899PubMedCrossRef

51.

Dhillon VS, Yeoh E, Fenech M (2011) DNA repair gene polymorphisms and prostate cancer risk in South Australia–results of a pilot study. Urol Oncol 29(6):641–646PubMedCrossRef

52.

Hamdy MS, El-Haddad AM, Bahaa El-Din NM, Makhlouf MM, Abdel-Hamid SM (2011) RAD51 and XRCC3 gene polymorphisms and the risk of developing acute myeloid leukemia. J Invest Med Off Publ Am Fed Clin Res 59(7):1124–1130

53.

Liu L, Yang L, Mi Y et al (2011) RAD51 and XRCC3 polymorphisms: impact on the risk and treatment outcomes of de novo inv(16) or t(16;16)/CBFbeta-MYH11(+) acute myeloid leukemia. Leuk Res 35(8):1020–1026PubMedCrossRef

54.

Gil J, Ramsey D, Stembalska A et al (2012) The C/A polymorphism in intron 11 of the XPC gene plays a crucial role in the modulation of an individual’s susceptibility to sporadic colorectal cancer. Mol Biol Rep 39(1):527–534PubMedCrossRef

55.

Romanowicz-Makowska H, Smolarz B, Zadrozny M et al (2012) The association between polymorphisms of the RAD51-G135C, XRCC2-Arg188His and XRCC3-Thr241Met genes and clinico-pathologic features in breast cancer in Poland. Eur J Gynaecol Oncol 33(2):145–150PubMed

56.

Zhang L, Ruan Z, Hong Q et al (2012) Single nucleotide polymorphisms in DNA repair genes and risk of cervical cancer: a case-control study. Oncol Lett 3(2):351–362PubMedCentralPubMed

57.

Mucha B, Przybylowska-Sygut K, Dziki L, Dziki A, Sygut A, Majsterek I (2012) Lack of association between the 135G/C RAD51 gene polymorphism and the risk of colorectal cancer among Polish population. Polski przeglad chirurgiczny 84(7):358–362PubMedCrossRef

58.

Romanowicz-Makowska H, Smolarz B, Samulak D et al (2012) A single nucleotide polymorphism in the 5′ untranslated region of RAD51 and ovarian cancer risk in Polish women. Eur J Gynaecol Oncol 33(4):406–410PubMed

59.

Romanowicz-Makowska H, Samulak D, Michalska M et al (2012) RAD51 gene polymorphisms and sporadic colorectal cancer risk in Poland. Pol J Pathol Off J Pol Soc Pathol 63(3):193–198CrossRef

60.

Romanowicz-Makowska H, Smolarz B, Gajecka M et al (2012) Polymorphism of the DNA repair genes RAD51 and XRCC2 in smoking- and drinking-related laryngeal cancer in a Polish population. Arch Med Sci AMS 8(6):1065–1075CrossRef

61.

Gresner P, Gromadzinska J, Polanska K, Twardowska E, Jurewicz J, Wasowicz W (2012) Genetic variability of Xrcc3 and Rad51 modulates the risk of head and neck cancer. Gene 504(2):166–174PubMedCrossRef

62.

Romanowicz-Makowska H, Smolarz B, Polac I, Sporny S (2012) Single nucleotide polymorphisms of RAD51 G135C, XRCC2 Arg188His and XRCC3 Thr241Met homologous recombination repair genes and the risk of sporadic endometrial cancer in Polish women. J Obstet Gynaecol Res 38(6):918–924PubMedCrossRef

63.

Smolarz B, Zadrozny M, Duda-Szymanska J et al (2013) RAD51 genotype and triple-negative breast cancer (TNBC) risk in Polish women. Pol J Pathol Off J Pol Soc Pathol 64(1):39–43CrossRef

64.

Krivokuca AM, Malisic EJ, Dobricic JD, et al. (2013) RAD51 135G > C and TP53 Arg72Pro polymorphisms and susceptibility to breast cancer in Serbian women. Familial Cancer: Epub ahead of print

65.

Mohindra A, Hays LE, Phillips EN, Preston BD, Helleday T, Meuth M (2002) Defects in homologous recombination repair in mismatch-repair-deficient tumour cell lines. Hum Mol Genet 11(18):2189–2200PubMedCrossRef

66.

Dudas A, Chovanec M (2004) DNA double-strand break repair by homologous recombination. Mutat Res 566(2):131–167PubMedCrossRef

67.

Lisby M, Rothstein R (2009) Choreography of recombination proteins during the DNA damage response. DNA Repair 8(9):1068–1076PubMedCentralPubMedCrossRef

68.

Yano K, Morotomi-Yano K, Adachi N, Akiyama H (2009) Molecular mechanism of protein assembly on DNA double-strand breaks in the non-homologous end-joining pathway. J Radiat Res 50(2):97–108PubMedCrossRef

69.

West SC (2003) Molecular views of recombination proteins and their control. Nat Rev Mol Cell Biol 4(6):435–445PubMedCrossRef

70.

O’Driscoll M, Jeggo PA (2006) The role of double-strand break repair—insights from human genetics. Nat Rev Genet 7(1):45–54PubMedCrossRef

71.

Khanna KK, Jackson SP (2001) DNA double-strand breaks: signaling, repair and the cancer connection. Nat Genet 27(3):247–254PubMedCrossRef

72.

Dixon K, Kopras E (2004) Genetic alterations and DNA repair in human carcinogenesis. Semin Cancer Biol 14(6):441–448PubMedCrossRef

73.

Wood RD, Mitchell M, Lindahl T (2005) Human DNA repair genes. Mutat Res 577(1–2):275–283PubMedCrossRef

74.

Mendoza J, Martinez J, Hernandez C et al (2013) Association between ERCC1 and XPA expression and polymorphisms and the response to cisplatin in testicular germ cell tumours. Br J Cancer 109(1):68–75PubMedCentralPubMedCrossRef

75.

Zeljic K, Supic G, Jovic N et al (2014) Association of TLR2, TLR3, TLR4 and CD14 genes polymorphisms with oral cancer risk and survival. Oral Dis 20(4):416–424PubMedCrossRef

76.

He YZ, Hu X, Chi XS et al (2014) Association between RAD51 gene polymorphism (-135G/C) and susceptibility of myelodysplastic syndrome and acute leukemia: evidence based on a meta-analysis. Tumour Biol J Int Soc Oncodev Biol Med 35(1):615–621CrossRef

77.

Sun H, Bai J, Chen F et al (2011) RAD51 G135C polymorphism is associated with breast cancer susceptibility: a meta-analysis involving 22,399 subjects. Breast Cancer Res Treat 125(1):157–161PubMedCrossRef

78.

Wang W, Li JL, He XF et al (2013) Association between the RAD51 135 G > C polymorphism and risk of cancer: a meta-analysis of 19,068 cases and 22,630 controls. PLoS One 8(9):e75153PubMedCentralPubMedCrossRef

Titel: Genetic 135G/C polymorphism of RAD51 gene and risk of cancer: a meta-analysis of 28,956 cases and 28,372 controls
verfasst von: Bei-bei Zhang
Dao-gang Wang
Chao Xuan
Gui-li Sun
Kai-feng Deng
Publikationsdatum: 01.12.2014
Verlag: Springer Netherlands
Erschienen in: Familial Cancer / Ausgabe 4/2014
Print ISSN: 1389-9600
Elektronische ISSN: 1573-7292
DOI: https://doi.org/10.1007/s10689-014-9729-0

Neu im Fachgebiet Onkologie

18.04.2024 | Wirbelsäulenmetastase | Nachrichten

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Genetic 135G/C polymorphism of RAD51 gene and risk of cancer: a meta-analysis of 28,956 cases and 28,372 controls

Abstract

Neu im Fachgebiet Onkologie

Stereotaktische Radiatio schlägt konventionelle Bestrahlung

Adjuvante Brustkrebstherapie: Doppelt hält besser

HNO-Op. auch mit über 90?

Manche Gestagene können das Risiko für Meningeome erhöhen

Update Onkologie

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 4/2014

Germline CDKN2A mutations in Brazilian patients of hereditary cutaneous melanoma

High-resolution melting (HRM) assay for the detection of recurrent BRCA1/BRCA2 germline mutations in Tunisian breast/ovarian cancer families

Association of interleukin-23 receptor gene polymorphisms with risk of bladder cancer in Chinese

“It’s all very well reading the letters in the genome, but it’s a long way to being able to write”: Men’s interpretations of undergoing genetic profiling to determine future risk of prostate cancer

Cribriform-morular variant of papillary thyroid carcinoma: an indication to screen for occult FAP

Distinct gene expression profiles in ovarian cancer linked to Lynch syndrome

Neu im Fachgebiet Onkologie

Stereotaktische Radiatio schlägt konventionelle Bestrahlung

Adjuvante Brustkrebstherapie: Doppelt hält besser

HNO-Op. auch mit über 90?

Manche Gestagene können das Risiko für Meningeome erhöhen

Update Onkologie